药明康德

Our commitment to social responsibility extends far beyond the lab. In honor of #InternationalDayofCharity, we are  proud to highlight our St. Paul site's 25th blood drive. Supported by our generous colleagues, the annual tradition collected 23 units of donated blood—each unit potentially saving up to 3 lives. Since 2019, our St. Paul team has collected 479 units, demonstrating our commitment to making a meaningful impact. This program is just one example of how our global workforce contributes to a healthier world, reinforcing our mission to enable life-saving #innovations. #LifeSciences #healthcare 

We are pleased to announce that WuXi AppTec has maintained its AA #MSCI ESG rating for the fourth consecutive year! The rating reflects WuXi AppTec’s commitment to incorporating environmental and social responsibilities into the company’s business strategies and operations. As an enabler of innovation, a trusted partner, and a contributor to the global pharmaceutical and life sciences industry, WuXi AppTec’s outstanding #ESG performance has been widely acknowledged by major global ESG rating agencies, including CDP, EcoVadis, S&P and Sustainalytics. https://lnkd.in/gT4Cwq7F

Take a look at our pioneering #CRDMO model.   Through the platform, we enable scientific innovations, develop distinct industry insights, quickly adapt to opportunities in new molecules as they rise, and continue to drive solid business growth. See how we’re accelerating the delivery of life-saving therapies and benefitting patients across the globe ⬇️   #Innovation #LifeSaving 

Our #H1Report performance demonstrates that our unique integrated #CRDMO business model can effectively meet the growing demand of customers worldwide.    We’re committed to continuously enhancing our capabilities and capacity to bring groundbreaking therapies to patients around the world.   See how we’re “doing the right thing and doing it right”: https://lnkd.in/ef-rsnzr

We are excited to announce that our new Munich site at the Life Science Center in Gräfelfing is now open, marking a key step forward in strengthening our CRDMO platform.   Located in the heart of the Munich biotech cluster, the new facility expands our structure-based drug discovery and lab testing capabilities – housing them under one roof. This will enhance our services to better support our customers in Europe and beyond.   Strong synergy across our sites enables innovation and collaboration, helping deliver more groundbreaking therapies to patients who need it most.   #Innovation #LifeSciences

We're delighted to announce that WuXi AppTec has been included in the #FTSE4Good Index Series for the second consecutive year!    This recognition demonstrates our exceptional performance in environmental, social, and governance (#ESG) practices driven by our commitment to advancing #sustainability and enabling #innovation for a healthier world. An independent assessment by FTSE Russell, An LSEG Business, a global index and data provider, scored WuXi AppTec above global industry standards.   Through our unique CRDMO and CTDMO business models, we continue to support customers’ needs by developing and delivering innovative new therapies to patients worldwide, working together towards a better and more sustainable future.

At WuXi STA, we foster an environment where diverse talents harmonize scientific excellence with creative thinking to drive #healthcare #breakthroughs. Analytical scientist Lena Ghadimipour, M.Sc thrives in this innovative culture at our San Diego site. Her collaborative team pushes boundaries together, united by a shared mission to accelerate life-changing treatments to patients worldwide. WuXi STA celebrates talents like Lena who blend passion and ingenuity to overcome complex challenges. Join us on this journey of healthcare innovation, fueled by curiosity and teamwork! https://lnkd.in/e2UeJY-d #WuXiSTASanDiego #Teamwork #Pharmaceuticals #TalentCelebration

At WuXi AppTec, our goals are rooted in our core values: doing the right thing and doing it right. We harness science and innovation not just for health advancements but also to safeguard our environment. Through minimizing our carbon footprint and adopting green practices, we embed sustainability in all we do.    On #WorldEnvironmentDay, we stand with the world to honor our planet and reinforce our dedication to environmental #sustainability.

WuXi AppTec, one of the world’s leading pharmaceutical Contract Research, Development and Manufacturing Organisations (CRDMO), has broken ground on a new facility in Singapore. The new CRDMO campus will expand WuXi AppTec’s offerings to its #pharmaceutical and #lifescience customers seeking expanded flexibility and scalability. Once it is fully operational, the facility is expected to provide approximately 1,600 employment opportunities in Singapore. As part of the CRDMO campus, WuXi AppTec will set up its Green Chemistry Centre of Excellence (CoE) for Drug Manufacturing. The CoE will focus on sustainable drug production and spearhead technologies around more efficient and environmentally friendly drug manufacturing processes. In addition, the company will also introduce its WuXi TIDES platform at the Singapore site to drive the development of peptide and oligonucleotide drugs, which are a new generation of targeted treatments. This will dovetail with Singapore’s efforts to build up capabilities in precision medicine, under our Research, Innovation and Enterprise (RIE) 2025 plan. Read about how WuXi AppTec’s new facility in #Singapore will help its customers around the world accelerate the development and commercialisation of life-saving therapies: https://lnkd.in/gxu3VS4z

Folks, In these complex times, clarity and truth are more important than ever. The reality is that legislation being considered in Congress would negatively impact industry innovation and upend the delivery of critical treatments to patients in need. Get the facts: https://lnkd.in/eViYEskV